ArticleThe Lancet. Global health2025
A rapid facility-level assessment of oxygen systems in 39 low-income and middle-income countries: a cross-sectional study.
Article in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Design and implementation of a multi-country targeted health facility assessment to measure integrated, people-centered, quality of services.PLOS global public health · 2026Article
- Large language models and global health equity: a roadmap for equitable adoption in LMICs.The Lancet regional health. Western Pacific · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundUnequal access to medical oxygen is a key driver of global inequities in morbidity and mortality. We aimed to describe reliable oxygen availability (ie, whether availability is uninterrupted) and functional availability (ie, whether oxygen system components are in working order) in 39 low-income and middle-income countries and to compare across WHO subregions.
methodsWe report cross-sectional survey data from primary, secondary, and tertiary level health facilities across six WHO subregions. Facilities were selected via purposive and stratified random sampling. Data collectors visited facilities from September 2022, to February 2023, to administer a standardised questionnaire to facility leadership. All approached facilities responded. Questions assessed reliable oxygen availability over the preceding 3 months and the functional availability of system components: oxygen sources (ie, cylinders, concentrators, plants, and liquid oxygen), distribution systems (ie, piping, cylinder transport, and respiratory tubing), delivery devices (ie, nasal interfaces, face masks, and advanced modalities), monitoring devices (ie, pulse oximeters and multiparameter monitors), and quality assurance (ie, oxygen concentration control and maintenance schedule). We report descriptive statistics and compare across subregions using χ
findingsOf 2884 surveyed facilities, 304 (24·5%) of 1241 primary facilities, 558 (52·4%) of 1064 secondary facilities, and 387 (66·8%) of 579 tertiary facilities reported reliable oxygen availability. Facilities across levels and subregions lacked system components, with statistically significant (p<0·05) differences in functional availability of all oxygen system components across subregions at all levels. For example, functional availability of cylinders ranged from 56·7% to 100·0%, piping from 7·5% to 94·6%, nasal cannulae from 56·3% to 96·4%, and pulse oximeters ranged from 47·8% to 96·4%, depending on level and subregion.
interpretationReliable oxygen availability was low across facility levels and subregions. There were significant disparities in the functional availability of oxygen system components across subregions, with important implications for global health equity and financing.
fundingThe Global Fund to Fight AIDS, Tuberculosis, and Malaria; the Yale National Clinician Scholars Program; the US National Center for Advancing Translational Sciences; the US National Heart, Lung, and Blood Institute; and the Yale Institute for Global Health. TRANSLATIONS: For the French translation of the abstract see Supplementary Materials section.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.